Hologic and R2 sign definitive agreement
A deal announced July 31 between women's health equipment vendor Hologic and R2 Technology calls for the integration of the CAD pioneer's ImageChecker into Hologic's Lorad Selenia full-field digital mammography system. The agreement grants Hologic
A deal announced July 31 between women's health equipment vendor Hologic and R2 Technology calls for the integration of the CAD pioneer's ImageChecker into Hologic's Lorad Selenia full-field digital mammography system. The agreement grants Hologic worldwide distribution rights for R2's OmniCAD Digital and film-based mammography suite of products customized for use with Selenia. The five-year agreement, which has two one-year renewal options, also provides Hologic the right to sell R2's film-based CAD products in conjunction with its digital-ready conventional screen-film mammography products.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
